(Q36257961)

13 August 2017

1 reference

title

Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention (English)

1 reference

13 August 2017

Streptococcus pneumoniae

1 reference

1 reference

Angela E Bridy-Pappas

1

1 reference

13 August 2017

Marya B Margolis

2

1 reference

13 August 2017

Kimberly J Center

3

1 reference

13 August 2017

Daniel J Isaacman

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

13 August 2017

1 reference

13 August 2017

25

1 reference

13 August 2017

1193-1212

1 reference

13 August 2017

9

1 reference

Pneumococcal serotypes and their clinical relevance

13 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Streptococcus pneumoniae colonisation: the key to pneumococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

An outbreak of pneumococcal pneumonia in two men's shelters

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Attacking the pneumococcus -- a hundred years' war.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

The human antibody response to simultaneous injection of six specific polysaccharides of pneumococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Novel penicillin-, cephalosporin-, and macrolide-resistant clones of Streptococcus pneumoniae serotypes 23F and 19F in Taiwan which differ from international epidemic clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Six year multicenter surveillance of invasive pneumococcal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Bacterial meningitis in the United States in 1995. Active Surveillance Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Bacterial meningitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Acute bacterial meningitis in adults. A review of 493 episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Clinical presentations, diagnosis, and prognostic factors of bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Predictors of occult pneumococcal bacteremia in young febrile children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Predictors of bacteremia in febrile children 3 to 36 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Revising the decision analysis for febrile children at risk for occult bacteremia in a future era of widespread pneumococcal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Management of fever without source in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Clinical policy for children younger than three years presenting to the emergency department with fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Clinical epidemiology of otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

A meta-analytic review of the risk factors for acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Pacifier as a risk factor for acute otitis media: A randomized, controlled trial of parental counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Utility of blood cultures in pediatric patients found to have pneumonia in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Effectiveness of pneumococcal polysaccharide vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Inefficacy of pneumococcal vaccine in a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Impact of Pneumococcal Vaccination on Morbidity and Mortality of Geriatric Patients: A Case-Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case-control study based on immediate responses in skin tests and specific IgE determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

PspA and PspC: their potential for use as pneumococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

Epidemiology of pneumococcal infections in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1193

10.1592/PHCO.2005.25.9.1193

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference